Tranzyme Pharma (TZYM) announced that its CFO, Richard Eisenstadt, is resigning effective...


Tranzyme Pharma (TZYM) announced that its CFO, Richard Eisenstadt, is resigning effective January 4, 2013, to pursue a new career opportunity. Upon that date, TZYM's controller, Rhonda Stanley, will assume the duties of principal financial officer and principal accounting officer.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs